BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
Clinical trial NCT06441890 · RECRUITING
Trial details
- NCT number
- NCT06441890
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-05
- Primary completion
- 2028-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.